Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Other 1

Conditions

Obesity 4Polycystic Ovary Syndrome 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Non-alcoholic Fatty Liver Disease 1Lipid Metabolism Disorders 1Diabetes Mellitus 1Cardiovascular Diseases 1Barrett Esophagus 1

Interventions

Therapeutics 2Exercise 2angiotensin I (1-7) 1Vitamin D 1Ursodeoxycholic Acid 1Tirzepatide 1Standard of Care 1Resistance Training 1Psychiatric Rehabilitation 1High-Energy Shock Waves 1Gelclair 1Docosahexaenoic Acids 1Diet 1Calcium Citrate 1Calcium Carbonate 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Docosahexaenoic Acids × Other × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡